Ironwood Pharmaceuticals, Inc. (IRWD) DCF Valuation

Valoración de DCF de Ironwood Pharmaceuticals, Inc. (IRWD)

US | Healthcare | Drug Manufacturers - Specialty & Generic | NASDAQ
Ironwood Pharmaceuticals, Inc. (IRWD) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Ironwood Pharmaceuticals, Inc. (IRWD) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Descubra el verdadero potencial de Ironwood Pharmaceuticals, Inc. (IRWD) con nuestra calculadora DCF avanzada! Personalice los supuestos clave, explore varios escenarios y evalúe cómo los diferentes cambios afectan la valoración de Ironwood Pharmaceuticals, Inc. (IRWD), todo dentro de una plantilla de Excel fácil de usar.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 428.4 389.5 413.8 410.6 442.7 447.4 452.1 456.9 461.7 466.5
Revenue Growth, % 0 -9.08 6.22 -0.76302 7.83 1.05 1.05 1.05 1.05 1.05
EBITDA 101.1 141.9 233.3 261.4 -924.9 71.7 72.4 73.2 74.0 74.7
EBITDA, % 23.6 36.43 56.39 63.67 -208.9 16.02 16.02 16.02 16.02 16.02
Depreciation 5.6 3.6 1.5 1.4 1.6 2.9 3.0 3.0 3.0 3.1
Depreciation, % 1.3 0.91497 0.36809 0.34535 0.35574 0.65733 0.65733 0.65733 0.65733 0.65733
EBIT 95.5 138.3 231.8 260.0 -926.4 69.1 69.8 70.5 71.3 72.0
EBIT, % 22.3 35.51 56.03 63.33 -209.25 15.43 15.43 15.43 15.43 15.43
Total Cash 177.0 362.6 620.1 656.2 92.2 317.8 321.2 324.6 328.0 331.4
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 117.2 122.4 114.0 115.5 129.1
Account Receivables, % 27.37 31.41 27.56 28.12 29.16
Inventories .6 .0 1.3 1.3 .0 .7 .7 .7 .7 .7
Inventories, % 0.15126 0.000000257 0.30211 0.30444 0 0.15156 0.15156 0.15156 0.15156 0.15156
Accounts Payable 5.5 .7 .9 .5 7.8 3.2 3.2 3.3 3.3 3.3
Accounts Payable, % 1.28 0.16969 0.22598 0.11763 1.77 0.71253 0.71253 0.71253 0.71253 0.71253
Capital Expenditure -7.2 -1.8 -.3 -.1 -.3 -2.1 -2.1 -2.1 -2.1 -2.2
Capital Expenditure, % -1.68 -0.47289 -0.06404787 -0.03312258 -0.06166217 -0.46195 -0.46195 -0.46195 -0.46195 -0.46195
Tax Rate, % -5.71 -5.71 -5.71 -5.71 -5.71 -5.71 -5.71 -5.71 -5.71 -5.71
EBITAT -24.8 134.9 610.5 180.3 -979.4 50.7 51.2 51.7 52.3 52.8
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -138.8 127.4 619.1 179.7 -983.1 46.8 50.8 51.3 51.8 52.4
WACC, % 3.29 5.5 5.55 4.86 5.55 4.95 4.95 4.95 4.95 4.95
PV UFCF
SUM PV UFCF 218.9
Long Term Growth Rate, % 0.50
Free cash flow (T + 1) 53
Terminal Value 1,183
Present Terminal Value 929
Enterprise Value 1,148
Net Debt 623
Equity Value 525
Diluted Shares Outstanding, MM 155
Equity Value Per Share 3.38

What You Will Get

  • Real IRWD Financial Data: Pre-filled with Ironwood Pharmaceuticals’ historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Ironwood Pharmaceuticals’ intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Customizable Forecast Inputs: Adjust essential metrics such as revenue growth, EBITDA %, and R&D expenditures.
  • Instant DCF Valuation: Automatically computes intrinsic value, NPV, and other key financial indicators.
  • High-Precision Accuracy: Leverages Ironwood's actual financial data for dependable valuation results.
  • Effortless Scenario Analysis: Easily evaluate various assumptions and analyze different outcomes.
  • Efficiency Booster: Streamline your workflow by avoiding the complexity of creating valuation models from the ground up.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Ironwood Pharmaceuticals data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Ironwood Pharmaceuticals’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose Ironwood Pharmaceuticals, Inc. (IRWD)?

  • Innovative Solutions: Cutting-edge therapies tailored to meet patient needs.
  • Proven Track Record: Strong clinical results and a commitment to quality.
  • Patient-Centric Approach: Focused on enhancing the patient experience and outcomes.
  • Expert Team: A dedicated group of professionals driving research and development.
  • Industry Recognition: A trusted name in pharmaceuticals with numerous accolades.

Who Should Use This Product?

  • Investors: Assess the fair value of Ironwood Pharmaceuticals (IRWD) to inform your investment choices.
  • CFOs: Utilize a sophisticated DCF model for accurate financial reporting and analysis.
  • Consultants: Easily customize the template for client valuation reports.
  • Entrepreneurs: Understand financial modeling techniques employed by leading pharmaceutical companies.
  • Educators: Implement it as a resource to teach valuation methods effectively.

What the Template Contains

  • Historical Data: Includes Ironwood Pharmaceuticals’ past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Ironwood Pharmaceuticals’ intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Ironwood Pharmaceuticals’ financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.